Lazard Asset Management LLC Adverum Biotechnologies, Inc. Transaction History

Lazard Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.75 - $1.26 $417 - $701	-557 Reduced 5.31%	9,932 $7,000
Q3 2023 Nov 14, 2023	BUY	$1.5 - $2.33 $645 - $1,001	430 Added 4.27%	10,489 $15,000
Q2 2023 Aug 14, 2023	BUY	$0.68 - $1.59 $6,840 - $15,993	10,059 New	10,059 $15,000
Q2 2021 Aug 12, 2021	SELL	$3.36 - $10.56 $356 - $1,119	-106 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$9.84 - $14.26 $1,043 - $1,511	106 New	106 $1,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $449M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Lazard Asset Management LLC with notifications on news.